These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32507807)

  • 1. [Acquired hemophilia A complicated by dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid].
    Matsumoto T; Kaneda Y; Yamaguchi K; Nakamura N; Nakamura H; Ninomiya S; Kitagawa J; Kanemura N; Shimizu M; Tsurumi H
    Rinsho Ketsueki; 2020; 61(5):451-454. PubMed ID: 32507807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bullous Pemphigoid Triggered by Thermal Burn Under Medication With a Dipeptidyl Peptidase-IV Inhibitor: A Case Report and Review of the Literature.
    Mai Y; Nishie W; Sato K; Hotta M; Izumi K; Ito K; Hosokawa K; Shimizu H
    Front Immunol; 2018; 9():542. PubMed ID: 29706950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case Report: Appearance of Various Disease-Specific Antibodies After the Onset of Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid.
    Iwamoto Y; Anno T; Koyama K; Kawasaki F; Kaku K; Tomoda K; Sugiyama S; Aoyama Y; Kaneto H
    Front Immunol; 2022; 13():843480. PubMed ID: 35309321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid: A comparative study of 100 patients with bullous pemphigoid and diabetes mellitus.
    Chanprapaph K; Pratumchart N; Limtong P; Rutnin S; Sukasem C; Kungvalpivat P; Triamchaisri S; Suchonwanit P
    J Dermatol; 2021 Apr; 48(4):486-496. PubMed ID: 33543537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dipeptidyl Peptidase-4 Inhibitor Induced Bullous Pemphigoid Complicated by Acquired Reactive Perforating Dermatosis.
    Gambichler T; Espey B; Doerler M; Stranzenbach R
    Actas Dermosifiliogr; 2022 Oct; 113(9):914-915. PubMed ID: 35636509
    [No Abstract]   [Full Text] [Related]  

  • 6. Decrease in eosinophils infiltrating into the skin of patients with dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid.
    Chijiwa C; Takeoka S; Kamata M; Tateishi M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Watanabe S; Tada Y
    J Dermatol; 2018 May; 45(5):596-599. PubMed ID: 29411416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bullous pemphigoid is a common associated disorder with acquired haemophilia A.
    Abdul-Halim NA; Ng HJ
    Int J Hematol; 2021 Jan; 113(1):58-62. PubMed ID: 32949372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bullous pemphigoid associated with use of dipeptidyl peptidase-4 inhibitor.
    Kano Y; Kato M
    CMAJ; 2022 May; 194(20):E705. PubMed ID: 35609911
    [No Abstract]   [Full Text] [Related]  

  • 9. Bullous pemphigoid associated with acquired hemophilia a: a rare association of autoimmune disease.
    Aljasser MI; Sladden C; Crawford RI; Au S
    J Cutan Med Surg; 2014; 18(2):123-6. PubMed ID: 24636438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
    Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acquired hemophilia A associated with bullous pemphigoid and multiple myeloma: a case report].
    Sourdeau É; Clauser S; Prud'Homme R; Bardet V; Calmette L
    Ann Biol Clin (Paris); 2019 Apr; 77(2):179-183. PubMed ID: 30882350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association between bullous pemphigoid and dipeptidyl peptidase-4 inhibitors and impact of their withdrawal].
    Martín-Enguix D; Ruiz-Villaverde R; Galán-Gutiérrez M; Cabrerizo-Carvajal AM
    Aten Primaria; 2023 Apr; 55(4):102586. PubMed ID: 36842360
    [No Abstract]   [Full Text] [Related]  

  • 13. Neutrophil to lymphocyte ratio is predictive of severe complications and mortality in patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid: A retrospective longitudinal observational study.
    Sugiyama S; Yamamoto T; Aoyama Y
    J Am Acad Dermatol; 2022 Jun; 86(6):1387-1390. PubMed ID: 34058280
    [No Abstract]   [Full Text] [Related]  

  • 14. The association of bullous pemphigoid with dipeptidyl-peptidase 4 inhibitors: a ten-year prospective observational study.
    Lambadiari V; Kountouri A; Kousathana F; Korakas E; Kokkalis G; Theotokoglou S; Palaiodimou L; Katsimbri P; Ikonomidis I; Theodoropoulos K; Papadavid E
    BMC Endocr Disord; 2021 Feb; 21(1):23. PubMed ID: 33573656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bullous pemphigoid with dipeptidyl peptidase-4 inhibitors: Clinical features and pathophysiology.
    Murakami T; Yabe D; Inagaki N
    J Diabetes Investig; 2019 Sep; 10(5):1168-1170. PubMed ID: 30989811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bullous Pemphigoid Associated with Acquired Hemophilia A: A Case Report and Review of the Literature.
    Fakprapai W; Wattanakrai P
    Case Rep Dermatol; 2019; 11(2):130-139. PubMed ID: 31182947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-medications and dipeptidyl peptidase-4 inhibitors associated bullous pemphigoid.
    Gravani A; Christou P; Tigas S; Bassukas ID
    An Bras Dermatol; 2021; 96(6):782-784. PubMed ID: 34600789
    [No Abstract]   [Full Text] [Related]  

  • 18. Bullous Pemphigoid Associated with the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin in a Patient with Liver Cirrhosis Complicated with Rapidly Progressive Hepatocellular Carcinoma.
    Harada M; Yoneda A; Haruyama S; Yabuki K; Honma Y; Hiura M; Shibata M; Matsuoka H; Uchiwa Y
    Intern Med; 2017 Sep; 56(18):2471-2474. PubMed ID: 28824076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired Hemophilia A associated with bullous pemphigoid: A rare combination.
    Bragança M; Valente C; Ferreira AI; Freitas-Silva M
    Transfus Apher Sci; 2022 Apr; 61(2):103337. PubMed ID: 34903450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Two elderly patients with difficult-to-treat acquired hemophilia A].
    Saito M; Morioka M
    Nihon Ronen Igakkai Zasshi; 2016; 53(4):424-430. PubMed ID: 27885231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.